Stimulant-Associated Deaths in US

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, FEBRUARY 1, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7850?guestAccessKey=4ec3f879-e5de-498f-918b-4539f43d31a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020121

 

What The Study Did: Researchers looked at changes in the rate of deaths associated with the use of illicit (such as cocaine) and medical  stimulants in the United States from 2010 to 2017.

Authors: Joshua C. Black, Ph.D., of Rocky Mountain Poison & Drug Safety in Denver, is the corresponding author.

 

(doi:10.1001/jamainternmed.2020.7850)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.